Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000215313 | SCV000270953 | likely benign | not specified | 2015-12-22 | criteria provided, single submitter | clinical testing | p.Gln2257Gln in Exon 21 of TRIOBP: This variant is not expected to have clinical significance because it does not alter an amino acid residue, is not located wi thin the splice consensus sequence, and has been identified in 0.1% (55/53588) o f European chromosomes by the Exome Aggregation Consortium (http://exac.broadins titute.org/; dbSNP rs200793989). |
Eurofins Ntd Llc |
RCV000731421 | SCV000859238 | uncertain significance | not provided | 2018-01-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000731421 | SCV001064207 | likely benign | not provided | 2023-12-28 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000731421 | SCV001803225 | uncertain significance | not provided | 2023-11-30 | criteria provided, single submitter | clinical testing | In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003947715 | SCV004774985 | likely benign | TRIOBP-related disorder | 2024-07-12 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |